Forecast Maintained: Moderate Growth To Continue

BMI View: BMI's projection that Hungary will achieve only marginal pharmaceutical market growth in 2010 has been confirmed. Supported by our latest macroeconomic forecasts, our long-term outlook for Hungary's drug market expenditure remains modest. High unemployment and a reliance on net exports to drive economic growth will limit increases in private consumption in the medium term. Furthermore, an amendment to legislation to change tax write-off rules for Hungarian drugmakers could significantly affect the net profit margins of domestic produces in 2011.

To read the full article, please choose one of the following options: